Generate a tailored SOP for Dr. Erik Ranheim. Improve your application with a focused, well-structured draft.
Dr. Erik Ranheim is a Professor and Department Chair at the University of Wisconsin School of Medicine and Public Health, specializing in Pathology and Laboratory Medicine. His research focuses on understanding the complex interactions between immune systems and tumor cells, particularly through the frizzled/Wnt/beta-catenin signaling pathway. His laboratory investigates normal and neoplastic lymphoid development, with a particular emphasis on hematopoietic leukemic stem cell biology. Dr. Ranheim's work involves assessing the immune system's potential in treating cancers and the mechanisms by which tumor cells evade immune responses. He collaborates with members of the UW Carbone Cancer Center to explore anti-tumor immunity in mouse models and human patients. His clinical interests are centered on hematopathology, particularly chronic lymphocytic leukemia and B cell malignancies, as well as the insights provided by studies of the beta-catenin pathway in regulating hematopoietic stem cell fate.
University of Wisconsin School of Medicine and Public Health • Madison, WI
Leading the Department of Pathology and Laboratory Medicine and conducting advanced research in tumor immunology and hematopathology.
Admissions processed through the Neuroscience Training Program (NTP).